All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Radiofrequency ablation for Barrett's esophagus-related neoplasia

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F18%3AA1901VYK" target="_blank" >RIV/61988987:17110/18:A1901VYK - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11110/18:10381814 RIV/00023001:_____/18:00077429

  • Result on the web

    <a href="http://dx.doi.org/10.23736/S0026-4733.18.07783-0" target="_blank" >http://dx.doi.org/10.23736/S0026-4733.18.07783-0</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.23736/S0026-4733.18.07783-0" target="_blank" >10.23736/S0026-4733.18.07783-0</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Radiofrequency ablation for Barrett's esophagus-related neoplasia

  • Original language description

    Barrett's esophagus (BE) is a premalignant condition associated with increased risk of developing esophageal adenocarcinoma. In the past, BE patients with high-grade intraepithelial neoplasia (IEN) or early adenocarcinoma (EAC) were indicated for esophagectomy. With the recent advance in endoscopy, endoscopic techniques have surpassed esophagectomy in the treatment of Barrett's esophagus-related neoplasia and minimized the treatment-related morbidity. Patients with IEN are candidates for endoscopic treatment - endoscopic mucosal resection (ER) of visible lesions and/or ablation therapy of flat Barrett's mucosa. ER combined with radiofrequency ablation (RFA) is now considered as a gold standard for treatment of patients with early Barrett's cancer. RFA is currently the most effective method of ablation used in the treatment of low-grade intraepithelial neoplasia/high-grade intraepithelial neoplasia without visible lesions and for ablation of residual Barrett's mucosa following ER/ESD of EAC or HGIN aiming to achieve complete eradication of Barrett's surface and thus, decreasing the risk of recurrent dysplasia or cancer. The rates of complete remission of neoplasia and metaplasia after completion of endoscopic treatment are 81-92.6% and 75-88.2%, respectively. The aim of this article is to review the principles, techniques, indications, efficacy and safety of this ablative method and surveillance of patients after successful treatment with RFA.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30212 - Surgery

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2018

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    MINERVA CHIRURGICA

  • ISSN

    0026-4733

  • e-ISSN

    0026-4733

  • Volume of the periodical

    73

  • Issue of the periodical within the volume

    4

  • Country of publishing house

    IT - ITALY

  • Number of pages

    12

  • Pages from-to

    366-377

  • UT code for WoS article

    000445223700003

  • EID of the result in the Scopus database

    2-s2.0-85051142594